Youn Benjamin S, Sen Arindom, Behie Leo A, Girgis-Gabardo Adele, Hassell John A
Pharmaceutical Production Research Facility (PPRF), Schulich School of Engineering, University of Calgary, Calgary, Alberta, Canada.
Biotechnol Prog. 2006 May-Jun;22(3):801-10. doi: 10.1021/bp050430z.
It has been hypothesized that breast tumor formation results from the activity of a scarce population of cells known as Breast Cancer Stem Cells (BrCSCs) and that the development of effective breast cancer therapies may therefore ultimately rely upon the ability to effectively target these cells for eradication. The scarcity of BrCSCs in vivo severely compromises research on these populations, as analyses are restricted to those requiring small cell numbers, and has become a major impediment to the development of therapeutic strategies against breast cancer. Through the culture of murine tissue aggregates containing a population of BrCSCs, this study demonstrates the ability of propagating this scarce population in a controlled and reproducible manner, within suspension bioreactors. A rigorous theoretical framework has been developed in order to understand and characterize the implications of oxygen mass transfer within aggregates upon scale-up and thereby provide a foundation for the scale-up of aggregate cultures. A two-factor, two-level factorial experimental design was also performed in order to assess the effects of inoculation density and hydrodynamic shear upon cell yield. We discovered that the culture of the murine aggregates in a relatively low shear environment (tau(max) = 0.20 Pa) and inoculated at 3.50 x 10(4) cells/mL resulted in the best yields for the range of conditions investigated in suspension bioreactors. A detailed study on the oxygen uptake kinetics of the aggregates also revealed that the uptake rates were not significantly affected by mass transfer limitations, as uptake rates of aggregate cultures were found to be comparable to those observed in single cell cultures. Cells propagated in a process controlled 500 mL suspension bioreactor resulted in growth kinetics that were comparable to those observed in 125 mL bioreactors. Doubling times in the 500 mL vessel were found to be 23.9 h and attained a maximum cell density of 1.20 x 10(6) cells/mL. After enumerating the number of BrCSCs, this resulted in an approximately 20-fold increase in BrCSC numbers in batch suspension cultures. With greater attention being applied to BrCSCs, their propagation in suspension bioreactors makes available experimental avenues that are not currently accessible and may thereby enable the development of more effective therapeutic drugs for the treatment of breast cancer.
据推测,乳腺肿瘤的形成源于一种数量稀少的细胞——乳腺癌干细胞(BrCSCs)的活动,因此有效的乳腺癌治疗方法的开发最终可能依赖于有效靶向这些细胞以将其根除的能力。体内BrCSCs的稀缺严重阻碍了对这些细胞群体的研究,因为分析仅限于那些需要少量细胞的研究,并且已成为开发针对乳腺癌的治疗策略的主要障碍。通过培养含有BrCSCs群体的小鼠组织聚集体,本研究证明了在悬浮生物反应器中以可控且可重复的方式扩增这种稀缺群体的能力。为了理解和表征聚集体内氧气传质对放大的影响,从而为聚集体培养的放大提供基础,已建立了一个严格的理论框架。还进行了两因素、两水平析因实验设计,以评估接种密度和流体动力剪切对细胞产量的影响。我们发现,在相对低剪切环境(τmax = 0.20 Pa)中培养小鼠聚集体并以3.50×10⁴个细胞/mL接种,在所研究的悬浮生物反应器条件范围内产生了最佳产量。对聚集体氧气摄取动力学的详细研究还表明,摄取速率不受传质限制的显著影响,因为聚集体培养物的摄取速率与单细胞培养物中观察到的摄取速率相当。在一个过程控制的500 mL悬浮生物反应器中繁殖的细胞产生的生长动力学与在125 mL生物反应器中观察到的相当。在500 mL容器中的倍增时间为23.9小时,最大细胞密度达到1.20×10⁶个细胞/mL。在对BrCSCs数量进行计数后,这导致分批悬浮培养中BrCSCs数量增加了约20倍。随着对BrCSCs的关注度提高,它们在悬浮生物反应器中的繁殖提供了目前无法获得的实验途径,从而可能使开发更有效的治疗乳腺癌的药物成为可能。